Standard Glass Lining IPO: Public Issue Subscribed 7x Within 3 Hours; GMP Hints Stellar Listing; Details

The Standard Glass Lining Technology Limited IPO opened for subscription today, marking a promising start in the Indian primary market. Investors can bid for shares in this pharma engineering equipment manufacturer until 5:00 pm on January 8, 2025. With a price band set between Rs 133 and Rs 140 per equity share, the IPO has already generated considerable buzz, fueled by robust anchor investor participation and a high grey market premium (GMP).

Key Highlights

IPO Size and Structure: The company aims to raise Rs 410.05 crore through this public issue, comprising a fresh issue of Rs 210 crore, and an offer-for-sale (OFS) of Rs 200.05 crore, providing partial exits for existing stakeholders.

Lot Size: Investors can bid in multiples of 107 shares per lot, ensuring accessibility for retail and institutional participants alike.

Registrar and Managers: Kfin Technologies has been appointed as the official registrar. IIFL Securities and Motilal Oswal Investment Advisors are managing the issue as lead managers.

Listing Date: The company's shares are expected to debut on stock exchanges on January 13, 2025.

Anchor Investor: Before the subscription period began, the IPO raised Rs 123.02 crore from anchor investors.

Grey Market Sentiment

The grey market premium (GMP) for Standard Glass Lining shares stood at Rs 98 on the opening day. This indicates a potential listing price of around Rs 238 per share, a 70% premium to the issue's upper price band of Rss 140. GMP is often seen as a predictor of listing-day performance.

Day 1 Subscription Update

By 1 pm on the opening day, the IPO had already been subscribed 6.82 times. Retail Portion has been subscribed 8.77 times, and Non-Institutional Investors (NII) subscribed 11.04 times. With two more days of bidding remaining, the IPO is expected to witness even higher subscription figures across categories.

Utilization of Proceeds

The proceeds from the fresh issue will be deployed to support the company's growth objectives:
Business Expansion: Investments in machinery and equipment to increase manufacturing capacity.
Debt Reduction: Strengthening the balance sheet by repaying existing liabilities.
Corporate Purposes: Enhancing operational efficiency and funding other general business needs.
The OFS component will allow existing shareholders to monetize a portion of their holdings, providing additional liquidity.

Company Overview

Standard Glass Lining Technology is a leading player in the pharma engineering equipment sector, specializing in products like reaction systems, storage systems, and drying systems.